Correvio Pharma Corp. Finite-Lived Intangible Assets, Accumulated Amortization
Correvio Pharma Corp. had Finite-Lived Intangible Assets, Accumulated Amortization of $19.76 million as of 2019-12-31, per its 20-F filed 2020-04-30.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Finite-Lived, after Accumulated Amortization
us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization · last filed 2020-04-30
- 2019-12-31: Finite-Lived Intangible Assets, Accumulated Amortization $19.76M.
- 2018-12-31: Finite-Lived Intangible Assets, Accumulated Amortization $16.30M.
- 2017-12-31: Finite-Lived Intangible Assets, Accumulated Amortization $13.37M.
- 2016-12-31: Finite-Lived Intangible Assets, Accumulated Amortization $9.80M.
| Period end | Finite-Lived Intangible Assets, Accumulated Amortization |
|---|---|
| 2019-12-31 | $19.76M 20-F · filed 2020-04-30 |
| 2018-12-31 | $16.30M 20-F · filed 2020-04-30 |
| 2017-12-31 | $13.37M 40-F · filed 2019-03-13 |
| 2016-12-31 | $9.80M 20-F · filed 2018-04-30 |
| 2015-12-31 | $7.05M 40-F · filed 2017-03-29 |
| 2014-12-31 | $5.08M 40-F · filed 2016-03-29 |
| 2013-12-31 | $3.07M 40-F · filed 2015-03-27 |